ReviewCurrent oncology (Toronto, Ont.)2023

Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?

Alessandro Sciarra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.